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While alternative splicing (AS) can potentially expand the functional repertoire of vertebrate genomes, relatively few AS
transcripts have been experimentally characterized. We describe our detailed manual annotation of vertebrate genomes,
which is generating a publicly available geneset rich in AS. In order to achieve this we have adopted a highly sensitive
approach to annotating gene models supported by correctly mapped, canonically spliced transcriptional evidence com-
bined with a highly cautious approach to adding unsupported extensions to models and making decisions on their func-
tional potential. We use information about the predicted functional potential and structural properties of every AS
transcript annotated at a protein-coding or non-coding locus to place them into one of eleven subclasses. We describe
the incorporation of new sequencing and proteomics technologies into our annotation pipelines, which are used to iden-
tify and validate AS. Combining all data sources has led to the production of a rich geneset containing an average of 6.3AS
transcripts for every human multi-exon protein-coding gene. The datasets produced have proved very useful in providing
context to studies investigating the functional potential of genes and the effect of variation may have on gene structure
and function.
Database URL: http://www.ensembl.org/index.html, http://vega.sanger.ac.uk/index.html
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Introduction
The alternative splicing (AS) of RNA transcripts can produce
multiple mature transcripts from a single locus and the vast
majority of human multi-exon loci are subject to AS (1, 2).
AS is observed at a high frequency in vertebrates (3), but
has also been shown to occur in invertebrate, plant and
fungal genomes (4–7). It is believed that AS can act to
expand the protein repertoire of the cell (8) encoding al-
ternative protein forms with biological functions that differ
from the canonical product of the locus (9). However, AS
transcripts may contain profound changes to the structural
and functional domains of the canonical product (10), and
the loss or disruption of such domains may render the
translation product non-functional (11). Instead, it has
been proposed that certain non-translated AS transcripts
may play a role in gene regulation (12–14). For example,
the generation of AS transcripts containing premature ter-
mination codons has been shown to regulate the transla-
tional output of members of the SR gene family (15),
whereby such transcripts become targets for the
nonsense-mediated decay (NMD) pathway (16).
Capturing the detail and complexity of AS is important in
providing context to any analysis that relies on knowledge
of the position, structure and functional potential of gene
loci. Our manual annotation of the ENCODE pilot regions
(17) was demonstrably more accurate than any computa-
tional method in terms of the sensitivity and specificity of
models produced (18, 19) and these qualities remain high in
current annotation (Harrow, J. et al., submitted for publi-
cation, Howald, C. et al., submitted for publication). In col-
laboration with the GENCODE consortium, we are
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project (20) and this publicly available geneset has also
been used by the 1000 Genomes Loss of Function project
(21) among others.
Overview of manual annotation
of AS
We annotate all transcript models supported by experimen-
tal evidence, predominantly ESTs and mRNAs. Manual
annotation is well suited to interpreting issues of sequence
quality that can compromise the ability of many computa-
tional gene builders to utilize ESTs, extracting useful infor-
mation from them using alignment visualisation tools such
as Blixem and Dotter (22, Barson,G. and Griffiths,E., manu-
script in preparation). As such, there is no quality-based
pre-filtering of ESTs and mRNAs on the basis of e.g. library
or tissue of origin, rather every single piece of transcript
evidence is considered on its own merits. Where conven-
tional transcriptional data such as ESTs and mRNAs are
unavailable, we utilize other evidence to support the anno-
tation of a transcript model, for example, experimental
data from publications, conservation in other species, and
data from new technologies such as RNA-Seq data and
proteomic data. The evidence used to construct each tran-
script model is made viewable to the user via the Vega (23)
and Ensembl (24) browsers. Furthermore, our manual ap-
proach allows us to construct transcript models with higher
information content than is possible via automated anno-
tation. First, we provide a carefully considered interpret-
ation of the functional potential of the model; e.g.
whether the transcript has a full-length CDS, is subject to
NMD or non-stop decay (NSD) (25), or has a retained intron
that would disrupt the CDS. Secondly, we tag any
non-standard features possessed by the model with stand-
ard ontologies; for example, where the model contains
non-canonical splice sites supported by cross-species
conservation.
We avoid extrapolation wherever possible. To avoid
both combinatorial inflation of AS transcripts and the as-
signment of potentially incompatible AS events in the same
transcript, we do not merge shorter pieces of evidence
(such as ESTs) to create a full-length transcript model
unless there is absolutely no other evidence (mRNA or pro-
tein) that spans the full-length of the locus. Similarly, to
avoid over-predicting the functional potential of an AS
transcript we do not flag models as NMD or NSD where
the true end of the transcript cannot be identified due to
30-truncation. Nonetheless, we annotate models even in the
absence of interpretable function. For example, we have
annotated models that lack a CDS or polyadenylation
features from the earliest days of the human genome pro-
ject (26). However, it is only recently that such transcripts
have been recognized as belonging to a class of long
non-coding RNA (lncRNA), the putative regulatory function
of which are only starting to be confirmed in the laboratory
(27). With  10000 annotated lncRNA gene loci containing
 16000 transcripts, the GENCODE geneset currently con-
tains the largest set of manually annotated lncRNAs avail-
able (Derrien,T. et al., submitted for publication). It is for
similar reasons that we annotate the retained intron class
of AS variants despite questions over their functional rele-
vance. While retained intron events have traditionally been
interpreted as immature or incorrectly processed RNA spe-
cies captured during cytoplasmic RNA preparations, there is
evidence from both bioinformatic (28) and laboratory stu-
dies that a subset of such transcripts may be functional.
However, due to the continued uncertainty over their val-
idity [e.g. whether they disproportionately derived from
tumour cell lines (29)], and in order not to add contamin-
ation to protein databases, we do not annotate AS tran-
scripts with retained introns as protein-coding unless there
is additional evidence to do so.
Methodology for the identifying
and biotyping alternative splice
variants
Manual annotation of AS is performed according to the
guidelines of the HAVANA (Human And Vertebrate
Analysis and Annotation) group; the current set can be
accessed at ftp://ftp.sanger.ac.uk/pub/annotation. Tran-
script models are built based on the alignment of transcrip-
tomic (ESTs and mRNAs) and proteomic data from GenBank
and Uniprot. These data are aligned to the reference
genome sequence using BLAST (30), with a subsequent re-
alignment of transcript data by Est2Genome (31). Gene
models are manually interpreted from the alignments by
annotators using the otterlace annotation interface (32).
Alignments are navigated using the Blixem alignment
viewer (22). Visual inspection of the dot-plot output from
the Dotter tool (22) is used to resolve any alignment with
the genomic sequence that is unclear or absent from
Blixem. Short alignments (<15 bases) that cannot be visua-
lized using Dotter are detected using the Zmap DNA Search
pattern-matching tool (33). The annotation of exon-intron
boundaries requires the presence of canonical splice sites
(after (34) but defined as GT–AG, GC–AG and AT–AC donor
and acceptor sites) and any deviation from this rule requires
the use of clear explanatory tags. It is important to note
that models are only extended to the extent of the hom-
ology with supporting evidence; for example an AS model
based on a 30-truncated EST will not be extended to cover
the full length of the locus. Any models based on truncated
evidence are clearly tagged to indicate this.
.............................................................................................................................................................................................................................................................................................
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tional evidence at an individual locus are used to build
transcript models. Single exon, unspliced ESTs are not
used to construct new transcript models, but may be used
to extend the final exon of a model where they support the
annotation of polyadenylation features; similarly, unspliced
mRNAs can be used to extend the final exon of a model or
to build novel, single exon transcript models. All AS events
described in Figure 1 are annotated; exon skipping (single
or multiple exons), intron retention, alternative splice
donor site (50- and 30-shifts), alternative splice acceptor
[50- and 30-shifts, including NAGNAG (35)], alternative first
exon, alternative final exon and mutually exclusive exon
pairs. Although it is an important concept in describing
AS, we do not routinely define a reference transcript at a
locus or classify the nature of the AS event. AS is not limited
to one event per transcript and transcripts may contain
multiple AS events.
As part of the GENCODE consortium we work closely
with computational collaborators to produce the reference
human geneset for the ENCODE project. To ensure the
highest possible sensitivity and specificity are maintained,
manual annotation is both informed by, and checked
against, computational predictions of alternatively spliced
transcripts by PASA (36) and Ensembl (37, 38), supported
introns (Mark Diekhans, personal communication), U12 in-
trons from U12DB (39), coding exons by CONGO (40) and
pseudogenes by PseudoPipe (41, 42), Retrofinder (43) and
Pseudofinder (44). Computational gene predictions are vis-
ible in the annotation interface to provide hints to annota-
tors during first-pass manual annotation and also
compared to completed manual annotation to identify
potential missing features and flag them for manual
re-investigation. Annotated gene models are validated by
the high-throughput sequencing of pooled RT–PCR reac-
tions from eight tissues (brain, heart, kidney, liver, lung,
spleen, skeletal muscle and testis) where primers are
designed to check single or multiple exon-exon junctions
(designated as RT–PCR-Seq) (Howald,C. et al., submitted
for publication).
Once their exon-intron structure is resolved, all AS tran-
scripts are assigned to a subclass based on their putative
functional potential and structural properties. These
subclasses are designated ‘biotypes’ as they aim to reflect
biologically relevant features of the transcript. The
protein-coding potential of the transcript is initially deter-
minedon thebasis of similarity toknown protein sequences,
or homology to orthologous and paralogous proteins.
Further information to aid classification may be drawn
from the presence of Pfam functional domains (45) possible
alternative ORFs,retainedintronicsequenceand polyadeny-
lation features. Significantly, we also classify the transcripts
as putatively susceptible to NMD and NSD. In summary, we
explicitly link the structural impact of an AS event to its
effect on the functional potential of a transcript, enriching
theannotationatboththetranscriptandlocuslevel(46).For
example it is useful to know whether a transcript with a
single skipped exon retains an intact CDS or is subject to a
frameshift leading to the incorporation of a premature stop
codon likely to induce NMD. AS variants at lncRNA loci are
predominantly classified on the basis of known non-coding
function and positional relationship to protein-coding loci
(see Supplementary Figure 1 for more information on as-
signment of biotypes at protein-coding and lncRNA loci).
Figure 1. Alternative splicing events. All possible individual alternative splicing events are shown. Black arrowheads indicate
position of difference with a conceptual reference model (top).
.............................................................................................................................................................................................................................................................................................
Page 3 of 9
Database, Vol. 2012, Article ID bas014, doi:10.1093/database/bas014 Orginal article
.............................................................................................................................................................................................................................................................................................Incorporating automatically
derived transcripts into the manual
geneset
To maintain high sensitivity and specificity, manual anno-
tation is by necessity a slow process compared to computa-
tional gene prediction; a full first pass of the human
genome has not yet been completed. As such GENCODE
utilize Ensembl automated gene predictions as place-
holders until a locus or AS transcript can be manually anno-
tated. Currently  85% of the transcripts in the GENCODE
geneset are manually annotated, with the proportion
increasing with every release. Current technologies utilising
short read data such as RNA-Seq (1) and RT–PCR-Seq
(Howald,C. et al., submitted for publication) are likely to
be useful in revealing and validating new AS events.
While there is great interest in adding AS transcripts
based on these data, the short read lengths generally
only allow one or two introns to be captured by a single
read. Paired end reads can go some way to help, but in
longer genes a lack of connectivity between reads makes
it very difficult to deconvolute all possible combinations of
AS events to identify those which actually occur together.
Building complete transcript models from such data is likely
to remain problematic for the foreseeable future (http://
www.GENCODEgenes.org/rgasp/). As such, we currently
only accept split reads (i.e. reads mapping to two exons)
that validate an individual intron, using them to support
an AS transcript. We do not use gene predictions con-
structed by assembling a cluster of reads into a full-length
transcript as support for building manually annotated gene
models. Nonetheless we anticipate that longer sequencing
reads generated by new technologies such as those being
developed by Pacific Biosciences (http://www.pacificbios-
ciences.com) and Oxford Nanopore (http://nanoporetech.
com) will eventually provide connectivity between AS
events to provide a complete set of full-length AS tran-
scripts for both protein-coding and non-coding loci. In add-
ition, the advent of targeted proteomics approaches (47)
combined with higher resolution mass spectrometry has
some potential to enrich the set of AS transcripts and val-
idate protein-coding potential.
Complexity of publicly available
genesets
As a consequence of the approach we take to annotation
i.e. incorporation of ESTs and cross-species evidence, the
GENCODE geneset contains a large amount of AS com-
pared to other genesets. The GPCR56 locus encoding
human G protein-coupled receptor 56, for example, has
76 AS variants (Figure 2). The GENCODE v7 geneset contains
20687 protein-coding loci with 122909 transcripts.
Excluding single exon loci, protein-coding loci have a
mean of 6.31 transcripts, of these 2.59 are annotated
with coding potential and 1.8 give rise to a novel CDS.
The difference between the AS transcripts with coding
potential and those encoding a novel CDS indicates the
large numbers of AS observed in 50-UTRs (and to a much
lower extent 30-UTR). Approximately 60% of AS transcripts
are not annotated with a CDS due to our conservative ap-
proach to prediction of protein-coding potential; for ex-
ample where the transcript retains intronic sequenceor
has novel first or last exons within coding introns, and we
Figure 2. Zmap screenshot of the GPCR56 locus encoding human G protein-coupled receptor 56. This locus has 76 non-redundant
AS transcripts, the majority of which are EST based, 30 truncated and show variation in the 50 UTR. Red arrowhead indicates
50 UTR, green arrowhead indicates CDS and blue arrowhead indicate the two CCDS variants annotated at this locus.
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mination site has been captured.
A comparison of the GENCODE geneset with the RefSeq
geneset (which, like GENCODE, contains genome-wide an-
notation of protein-coding loci with a significant manual
annotation component) reveals the number of
protein-coding loci in each set to be similar (20687 versus
23191). The difference that does exist is likely due to the
fact that the GENCODE geneset is genome-centric whereas
the RefSeq geneset is transcript-centric; the latter can also
include loci that cannot be mapped to the current refer-
ence genome (GRCh37). The total number of loci in the
Consensus coding sequence (CCDS) geneset (48), which con-
tains CDSs agreed by Sanger, RefSeq and UCSC, is 18167,
comparable to the individual GENCODE and RefSeq
protein-coding genesets. However, While the total num-
bers of protein coding loci are similar for these sets, the
numbers of AS transcripts annotated vary greatly between
the genesets with GENCODE containing  3.3-fold more AS
transcripts than RefSeq and  5.2-fold more than CCDS (and
is still  1.4-fold higher when only AS transcripts with novel
CDS sequences are considered).
While protein-coding loci are enriched for AS it is import-
ant to note that, in our annotation, AS is not restricted to
this biotype. In the GENCODE geneset lncRNA loci com-
monly have annotated AS transcripts, with a mean of 1.6
transcripts per lncRNA locus. Notable examples include H19
(with 14 variants), the human ortholog of mouse Rosa26
(20 variants) and GAS5 (29 variants), the latter being par-
ticularly enriched for retained-intron variants that could
potentially play a role in regulating the snoRNA that lie
within its introns (Figure 3).
Validation of AS using conserva-
tion and transcription as proxies
While the existence of widespread AS is not disputed, the
overall contribution of AS to phenotype remains a topic of
great debate (11). To date, the vast majority of AS tran-
scripts lack published evidence for their functionality, and
even fewer have had their cellular roles defined in the la-
boratory. This is, at least in part, because the common bio-
chemical assays used to explore functionality are
low-throughput techniques, typically better suited to
single gene studies than to genome-wide surveys. Even
demonstrating the existence of AS protein products
in vivo is problematic due to the low coverage achieved
by high-throughput techniques such as Mass Spectrometry
(49). As such, we must rely on proxies to assess
genome-wide functionality for the immediate future. For
example, comparative studies may show that a particular
AS event is observed in different species; where conserva-
tion is observed over significant evolutionary time it can
then be hypothesized that the AS event is functional.
Recent studies in our group have found that  15% of AS
events are conserved between human and mouse (45). For
example, the PI4KB/Pi4kb genes which encode phosphati-
dylinositol 4-kinase, catalytic, beta in human and mouse
respectively share an exon skipping event that leads to
the utilisation of an internal translation start (Figure 4). In
addition, we have begun to incorporate data from new
sequencing technologies (e.g. RNA-Seq) to judge the func-
tionality of AS transcripts via two main routes. First, if an AS
transcript is consistently identified to be present at a sig-
nificantly lower level than a known functional transcript it
is considered likely to be the product of a noisy splicing
event; if it is found at a similar level it appears more
likely to be functional. Secondly, differential tissue expres-
sion patterns can identify putative functional transcripts; an
AS transcript that is consistently present in one or more
tissue types but absent from others, even when present at
a low level, is likely to be produced via a regulated process.
For example, the PDE4DIP locus encoding phosphodiester-
ase 4D interacting protein shows marked tissue specifi-
city for several AS transcripts with alternative first exons
(Figure 5).
Figure 3. Zmap screenshot of the GAS5 locus encoding
growth arrest-specific 5 (non-protein coding). This locus has
29 non-redundant AS transcripts, including many containing
retained introns. Black arrowheads indicate those introns
retained in at least one transcript. Green arrowheads indicate
intronic snoRNAs.
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Figure 5. Zmap screenshot of four representative full-length transcripts at the human PDE4DIP locus encoding phosphodiesterase
4D interacting protein (A) and screenshot of the Ensembl display of introns built using the Illumia Bodymap2 RNA-Seq dataset
(B). The three main transcription start sites (TSS) associated with the locus are circled and the primary tissue types in which the
TSSs are up or downregulated are indicated.
Figure 4. Zmap screenshot of the PI4KB/Pi4kb genes encoding phosphatidylinositol 4-kinase, catalytic, beta in human (left) and
mouse (right) respectively. Black ovals highlight exon-skipping event observed in both species, orange ovals highlight the species-
specific mRNA evidence supporting the annotation of the exon-skip event and red ovals highlight the conserved internal ATG
likely to be utilised in the event of the exon-skip.
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A full understanding of the AS transcript complement of a
coding locus is self-evidently desirable in its own right.
Furthermore, it can profoundly alter our interpretation of
how changes to a locus, either via natural variation or
experimental design can affect its function. For example,
we recently investigated 800 variants (SNPs and small
indels) that were predicted to lead to loss of function
(LoF) of the loci in which they were found (22). Following
full manual annotation of the loci and analysis of the
impact of the LoF variants,  36% were shown to affect
exons subject to AS. Clearly this could have a significant
bearing on the functional potential of the affected loci.
For example, an AS transcript that skips an exon may lead
to the exclusion of the LoF site from the mature mRNA,
avoiding any effect on function. Such a novel exon-skipping
transcript could putatively ‘rescue’ the functional potential
of a locus by encoding a CDS with some degree of
functional complementation. Also, where the AS is tissue
specific, any tissue that exclusively transcribes the
exon-skipping form is likely to avoid any functional conse-
quences of the LoF variant. Figure 6 shows the potential
complementation for the loss of one variant of the
PDE4DIP locus.
An understanding of AS has also proven important for
the production of large-scale knockout mouse resources,
such as those generated by the EUCOMM and KOMP pro-
grams (50). Using a ‘knockout-first’ approach (51), the iden-
tification of a critical exon or exons common to all coding
transcripts is essential for ablating gene function. Targeted
exons are typically asymmetric, which when deleted induce
a frameshift resulting in a truncated CDS that renders the
transcript susceptible to NMD. In the absence of detailed
manually annotated mouse gene structures, target exons
were selected using automated gene models following an
assessment of available transcriptome data (ESTs and
mRNA). Subsequent validation of knockout designs by
means of full manual annotation has revealed the complex
implications of AS for targeted transcripts. For example in
the Gls2 gene, initial targeting of exons 2–4 was shown to
rescue a transcript previously susceptible to NMD that
Figure 6. Zmap screenshot of all transcripts at the human PDE4DIP locus encoding phosphodiesterase 4D interacting protein. The
red arrowhead indicates the position of a disabling nonsense SNP, black arrowheads indicate the positions of alternative TSSs.
Figure 7. Validation of vector designs for Gls2 gene. The main
exon structure of Gls2 (main variant) is displayed alongside
NMD variants 1 and 2 based on mRNAs BC02566.1 and
AK039618.1, respectively. Hypothetical knockout (KO) tran-
scripts based on annotated structures are shown. Knockout
transcript, KO v1, is derived from the main variant and NMD
variant 1, where as the alternative version (Alt. KO v1) is
derived from NMD variant 2. Exons 1 to 7 are numbered
with coding regions displayed in green (main variant) or
white (NMD and KO variants) and untranslated regions
(UTR) shown in red or orange. The Gls2 glutaminase
domain is shown in grey, overlapping exon structure.
.............................................................................................................................................................................................................................................................................................
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(Figure 7). Although the resulting protein would have a
disrupted glutaminase domain, intact C-terminal Ank2 do-
mains containing ankyrin-repeats would remain and may
facilitate protein-protein interactions. Such a knockout
strategy, targeting exons 2–4, therefore compromises a
key criterion of the knockout programs to disrupt >50%
of the wild-type protein.
Conclusions
Since manual annotation was initiated as part of our
contribution to the human genome project we have
adopted a high-sensitivity, high-specificity approach. Our
identification and annotation of all experimentally
supported transcript models leads to an enrichment of AS
transcript present in our geneset compared to those found
in other manually curated genesets. The structure of every
model is manually checked, and we attempt to keep our
annotation up to date with current science (for example
systematically incorporating the annotation of NMD bio-
types). We continue to be cautious in terms of assigning
protein-coding potential in order to avoid making unsup-
ported decisions that may result in contamination in other
databases. This approach differs from other significant
databases whose main aim is to provide full-length protein
annotation. This approach has proved useful in capturing
features that had no obvious function at the time of their
annotation but have, in time, become better understood,
for example lncRNA loci. Our annotation of AS transcripts
lacking obvious function has also proved vitally important
for example in the reclassification of variants identified by
the 1000 Genomes project as causing LoF in human genes,
and in mouse knockout projects. As our catalogue of AS
events continues to expand, we will incorporate new meth-
ods to validate the functional potential of these transcripts
through the use of data from new sequencing and prote-
omics technologies.
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